PanCAN Chief Scientific and Medical Officer Anna Berkenblit discusses how PanCAN supports all patients diagnosed with ...

Experts discuss the integration of GLP-1 receptor agonists in treating neuroendocrine tumors, highlighting safety concerns ...

In an interview with Targeted Oncology at the 2025 North American Neuroendocrine Tumor Society (NANETS) Symposium, Michael ...

Acclaimed Indian actor Irrfan Khan passed away at 53 after a battle with a rare neuroendocrine tumor (NET). Diagnosed in 2018 ...

Three years ago Jordie Poncy was 39 years old and about to start his dream job: counseling patients at the Moffitt Cancer ...

Effective coordination among multidisciplinary team and individualized management strategies has emerged as a cornerstone of optimal NET care.

A Sydney patient with a rare and incurable cancer has seen promising results after receiving a new treatment currently in ...

Steve Jobs succumbed to a rare pancreatic neuroendocrine tumor. This cancer type differs significantly from common pancreatic ...

Across all ages, ADC incidence did not significantly vary, whereas NEN rates rose from 2004 to 2013, increasing between 10.1% (95% CI, 4.0%-16.5%) and 12.6% (95% CI, 7.2%-18.2%) per year before ...

PRRT retreatment may be well tolerated and confer a survival benefit in patients with well-differentiated, metastatic neuroendocrine tumors, a study suggests.

After a rare cancer diagnosis, Maria Menounos is raising awareness about the power of outside screenings and being your own ...

SAN DIEGO, Oct. 23, 2025 (GLOBE NEWSWIRE) -- Crinetics Pharmaceuticals, Inc. (Nasdaq: CRNX) today announced three abstracts from its clinical development programs will be presented at the upcoming ...